Center for Scientific Review; Notice of Closed Meetings, 32778-32779 [2023-10842]
Download as PDF
<![CDATA[
32778
Federal Register / Vol. 88, No. 98 / Monday, May 22, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: June 13, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 903 South 4th Street, Hamilton, MT
59840–2932 (Virtual Meeting).
Contact Person: Kristin L. McNally, PhD.,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 903 South 4th Street, Hamilton, MT
59840–2932, (406) 375–9641, mcnallyk@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 16, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10844 Filed 5–19–23; 8:45 am]
BILLING CODE 4140–01–P
ddrumheller on DSK120RN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
18:54 May 19, 2023
Jkt 259001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Cellular Immunology Core
Laboratory (N01).
Date: June 13, 2023.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E71,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Samita S. Andreansky,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E71,
Rockville, MD 20852, 240–669–2915,
samita.andreansky@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 15, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10846 Filed 5–19–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; New Technologies for the In
Vivo Delivery of Gene Therapeutics for an
HIV Cure (R01 Clinical Trial Not Allowed).
Date: June 28, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Barry J. Margulies, PhD.,
Scientific Review Officer, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G11, Rockville, MD 20852, (301) 761–7956,
barry.margulies@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 16, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10845 Filed 5–19–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiology of Eye Disease—2
Study Section.
Date: June 14–15, 2023.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
E:\FR\FM\22MYN1.SGM
22MYN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 98 / Monday, May 22, 2023 / Notices
Contact Person: Cibu Paul Thomas, Ph.D.
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011–H,
Bethesda, MD 20894 (301) 402–4341,
thomascp@mail.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social and Environmental Determinants of
Health Study Section.
Date: June 14–15, 2023.
Time: 9 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Ananya Paria, DHSC,
MPH, MS, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007H,
Bethesda, MD 20892, (301) 827–6513,
pariaa@mail.nih.gov.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group; Bioengineering of
Neuroscience, Vision and Low Vision
Technologies Study Section.
Date: June 15–16, 2023.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Tina Tze-Tsang Tang,
Ph.D. Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030
Bethesda, MD 20817, (301) 435–4436, tangt@
mail.nih.gov
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Social Psychology, Personality and
Interpersonal Processes Study Section.
Date: June 15–16, 2023.
Time: 9:30 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Janetta Lun, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007E,
Bethesda, MD 20892, (301) 435–5877,
janetta.lun@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Viral
Dynamics and Transmission.
Date: June 20–21, 2023.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Hotel George, 15 E Street NW,
Washington, DC 20001.
Contact Person: Sharon Isern, Ph.D.
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 810J,
Bethesda, MD 20892, (301) 435–0000,
iserns2@mail.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Cellular,
Molecular and Integrative Reproduction
Study Section.
VerDate Sep<11>2014
18:54 May 19, 2023
Jkt 259001
Date: June 20, 2023.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Anthony Wing Sang Chan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809K,
Bethesda, MD 20892, (301) 496–9392
chana2@csr.nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
Tumor Evolution, Heterogeneity and
Metastasis Study Section.
Date: June 21–22, 2023.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Rolf Jakobi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
MSC 7806, Bethesda, MD 20892, 301–435–
1718, jakobir@mail.nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Cellular and Molecular
Technologies Study Section.
Date: June 21–22, 2023.
Time: 9 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Tatiana V. Cohen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 5213,
Bethesda, MD 20892, 301–455–2364,
tatiana.cohen@nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group; Basic
Mechanisms of Cancer Health Disparities
Study Section.
Date: June 21–22, 2023.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Sulagna Banerjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (612) 309–2479, sulagna.banerjee@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 16, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10842 Filed 5–19–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
32779
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2023–0292]
National Chemical Transportation
Safety Advisory Committee; June 2023
Meetings
U.S. Coast Guard, Department
of Homeland Security.
ACTION: Notice of Federal advisory
committee meeting.
AGENCY:
The National Chemical
Transportation Safety Advisory
Committee (Committee) will conduct a
series of meetings over 2 days in
Washington DC, to discuss matters
relating to the safe and secure marine
transportation of hazardous materials.
The subcommittee meetings will also be
available by videoconference for those
unable to attend in person, however the
full committee meeting will be held in
person only. All meetings will be open
to the public.
DATES:
Meetings: National Chemical
Transportation Safety Advisory
Committee subcommittees will meet on
Wednesday, June 14, 2023, from 9 a.m.
to 5 p.m. Eastern Daylight Time (EDT)
each day. The full Committee will meet
on Thursday, June 15, 2023, from 9 a.m.
until 5 p.m. EDT. Please note these
meetings may close early if the
Committee has completed its business.
Comments and supporting
documents: To ensure your comments
are reviewed by Committee members
before the meeting, submit your written
comments no later than May 31, 2023.
ADDRESSES: The meeting will be held at
the American Bureau of Shipping
Group, 80 M Street Southeast, Suite 480,
Washington, DC 20003.
Pre-registration Information: Preregistration is required for in-person
access to the meeting or to attend the
subcommittee meetings by
videoconference. Public attendees will
be required to pre-register no later than
noon EDT on May 31, 2023, to be
admitted to the meeting. In-person
attendance may be capped due to
limited space in the meeting venue, and
registration will be on a first-come-firstserved basis. To pre-register, contact
Lieutenant Ethan Beard at
Ethan.T.Beard@uscg.mil. You will be
asked to provide your name, telephone
number, email, company, or group with
which you are affiliated, and whether
you wish to attend virtually or in
person; if a foreign national, also
provide your country of citizenship,
SUMMARY:
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 88, Number 98 (Monday, May 22, 2023)]
[Notices]
[Pages 32778-32779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10842]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the NIH Clinical Center
Research Hospital Board.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Pathophysiology of Eye Disease--2 Study
Section.
Date: June 14-15, 2023.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 32779]]
Contact Person: Cibu Paul Thomas, Ph.D. Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011-H, Bethesda, MD 20894 (301)
402-4341, [email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Social and Environmental Determinants of
Health Study Section.
Date: June 14-15, 2023.
Time: 9 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852.
Contact Person: Ananya Paria, DHSC, MPH, MS, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007H, Bethesda, MD 20892, (301)
827-6513, [email protected].
Name of Committee: Emerging Technologies and Training
Neurosciences Integrated Review Group; Bioengineering of
Neuroscience, Vision and Low Vision Technologies Study Section.
Date: June 15-16, 2023.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Tina Tze-Tsang Tang, Ph.D. Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030 Bethesda, MD 20817, (301)
435-4436, [email protected]
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Social Psychology, Personality and
Interpersonal Processes Study Section.
Date: June 15-16, 2023.
Time: 9:30 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Janetta Lun, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1007E, Bethesda, MD 20892, (301) 435-5877,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Viral Dynamics and Transmission.
Date: June 20-21, 2023.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: The Hotel George, 15 E Street NW, Washington, DC 20001.
Contact Person: Sharon Isern, Ph.D. Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 810J, Bethesda, MD 20892, (301) 435-0000,
[email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Cellular, Molecular
and Integrative Reproduction Study Section.
Date: June 20, 2023.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Anthony Wing Sang Chan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809K, Bethesda, MD 20892, (301)
496-9392 [email protected].
Name of Committee: Oncology 1-Basic Translational Integrated
Review Group; Tumor Evolution, Heterogeneity and Metastasis Study
Section.
Date: June 21-22, 2023.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6190, MSC 7806, Bethesda, MD 20892, 301-435-
1718, [email protected].
Name of Committee: Interdisciplinary Molecular Sciences and
Training Integrated Review Group; Cellular and Molecular
Technologies Study Section.
Date: June 21-22, 2023.
Time: 9 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852.
Contact Person: Tatiana V. Cohen, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 5213, Bethesda, MD 20892, 301-455-
2364, [email protected].
Name of Committee: Oncology 1-Basic Translational Integrated
Review Group; Basic Mechanisms of Cancer Health Disparities Study
Section.
Date: June 21-22, 2023.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Sulagna Banerjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (612) 309-2479,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 16, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-10842 Filed 5-19-23; 8:45 am]
BILLING CODE 4140-01-P
